Indomethacin ( DrugBank: Indomethacin )

3 diseases

225. 先天性腎性尿崩症

臨床試験数 : 15 / 薬物数 : 48 - (DrugBank : 18) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 65

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00478335 (ClinicalTrials.gov)	May 2007	23/5/2007	Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus	Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus	Nephrogenic Diabetes Insipidus	Drug: sildenafil;Drug: calcitonin;Drug: hydrochlorothiazide/amiloride;Drug: indomethacin;Drug: Place ...	University of Colorado, Denver	University of Aarhus	Completed	5 Years	25 Years	Male	4	N/A	United States;Denmark

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03473665 (ClinicalTrials.gov)	March 1, 2018	13/3/2018	Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis	Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis: a Pilot Study	Ankylosing Spondylitis;Axial Spondyloarthritis	Drug: Indomethacin;Drug: Diclofenac;Drug: Meloxicam;Drug: Celecoxib	Columbia University	NULL	Terminated	18 Years	N/A	All	9	Phase 4	United States
2	ChiCTR-TRC-11001417	2011-06-01	2011-07-10	clinical study of Mecenchymal Stem Cells transplantation in Ankylosing Spondylitis	clinical study of Mecenchymal Stem Cells transplantation in Ankylosing Spondylitis	Ankylosing Spondylitis (AS)	1:oral salicylazosulfapyridine and indomethacin;2:Mecenchymal Stem Cells(MSC) transplantation ;	Sun Yat-sen Memorial Hospital of Sun Yat-sen University	NULL	Recruiting			Both	1:80;2:80;	I+2 (Phase 1+Phase 2)	China
3	NCT02183168 (ClinicalTrials.gov)	July 2001	4/7/2014	Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Com ...	A Randomized, Open Label, 3-arm Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Dai ...	Spondylitis, Ankylosing	Drug: Meloxicam suppository;Drug: Meloxicam tablet;Drug: Indomethacin	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	192	Phase 3	NULL

臨床試験数 : 95 / 薬物数 : 148 - (DrugBank : 51) / 標的遺伝子数 : 53 - 標的パスウェイ数 : 142

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04207060 (ClinicalTrials.gov)	July 15, 2020	17/12/2019	Trial of Indomethacin in Chronic Pancreatitis	Phase 1/2 Trial of Indomethacin in Chronic Pancreatitis (The PAIR Trial)	Chronic Pancreatitis	Drug: Indomethacin;Drug: Placebos	Mayo Clinic	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Recruiting	18 Years	60 Years	All	32	Phase 2	United States